Michelson Prizes: Next Generation Grants – Empowering Breakthrough Research in Human Immunology and Vaccines
The Michelson Medical Research Foundation is now accepting purposes for the 2026 Michelson Prizes: Next Generation Grants—an bold initiative devoted to accelerating innovation in the sphere of human immunology and vaccine growth. With a deal with transformative science, these prestigious awards are designed to help early-career researchers whose work seeks to beat important challenges in international well being.
Each yr, the Michelson Prizes provide $150,000 grants to younger investigators who suggest high-impact, progressive analysis. The purpose is to catalyze contemporary considering and unconventional approaches in disciplines that intersect with immunology, vaccine discovery, and immunotherapy.
A Mission Rooted in Global Health Innovation
Backed by the Michelson Medical Research Foundation and administered in partnership with Next Frontier Advisors, the Michelson Prizes are awarded to help scientific excellence and creativity in addressing among the most urgent questions in immunology and vaccine science. The program particularly seeks concepts that push the boundaries of conventional analysis, bringing new disciplines and applied sciences into the dialog—resembling synthetic intelligence, nanotechnology, computational biology, and past.
Whether candidates are working in primary science, translational analysis, or rising fields, they’re invited to current novel ideas that might considerably advance our understanding of the immune system and improve vaccine efficacy and entry worldwide.
Who Should Apply?
While the Michelson Prizes are targeted on analysis in the fields of immunology, vaccine, and immunotherapy discovery, candidates from the total spectrum of associated disciplines, together with scientific analysis, biochemistry, molecular biology, protein engineering, laptop science, synthetic intelligence/machine studying, biophysics, nanotechnology, and so on., are inspired to apply. Download the application preview.
What Are They Looking For?
The choice committee is especially in proposals that:
Tackle long-standing roadblocks in human vaccine growth.
Improve the elemental understanding of immune processes.
Explore daring new applied sciences or theories that might revolutionize immunology and vaccine design.
Demonstrate cross-disciplinary considering and disruptive innovation.
The purposes are evaluated based mostly on originality, feasibility, and potential affect on international well being.
Application Criteria Details
$150,000 / 1-year grants to help analysis
Judged on innovation and potential affect
Research proposals should be on the subject of human immunology and vaccine growth
Researchers 35 years of age and underneath are eligible
The 2026 Next Generation Grants will likely be accepting purposes from April 1, 2025 – June 22, 2025
Download the full overview of the Michelson Prizes: Next Generation Grants
Timeline
Application Opens: April 1, 2025
Application Deadline: June 22, 2025, 11:59 pm EDT (UTC -4)
Shortlist Notification: September 1, 2025
Supplementary Information Due: October 2025
Final Award Notification: December 2025
Grant Cycle: January 1 – December 31, 2026
Applicants are inspired to organize early and obtain the application preview and pointers to evaluation necessities in full earlier than submission.
How to Apply
Applications should be submitted by way of the net application platform between April 1 and June 22, 2025. Only accomplished purposes submitted by the deadline will likely be thought of. Shortlisted candidates will likely be requested to offer extra documentation and clarification of their proposed work.
Learn More and Apply
Please evaluation the net Frequently Asked Questions first.
For particular questions on eligibility or the application course of, please e mail at [email protected].
For extra info, go to the official Michelson Prizes page.
For extra alternatives, please go to the web site of Opportunities For Youth.
Michelson Prizes: Next Generation Grants – Empowering Breakthrough Research in Human Immunology and Vaccines
